# FDA Inspection 1101234 - Minaris Regenerative Medicine, LLC - August 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/b8c76a20-3b0e-4e3c-93be-ff7add4709b3
Source feed: FDA_Inspections

> FDA Inspection 1101234 for Minaris Regenerative Medicine, LLC on August 26, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101234
- Company Name: Minaris Regenerative Medicine, LLC
- Inspection Date: 2019-08-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1284408 - 2025-09-29](https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/9080b763-c431-455a-aed1-0c069db6f2aa)
- [FDA Inspection 1020396 - 2017-04-26](https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/e232ed2b-f070-4e4b-85ab-8d662fc1b356)
- [FDA Inspection 886646 - 2014-06-17](https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/5a81bec9-2040-4d3a-a7ed-8fcfe398509d)

Company: https://www.keypedia.com/companies/minaris-regenerative-medicine-llc/b5fdb186-e2e7-416c-b89e-66d15dbf5509

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d